13,14-Dihydro-15-keto-PGF2α (PGFM) and sulprostone serum levels after application of sulprostone to postpartum women
- 31 October 1983
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 16 (3) , 173-179
- https://doi.org/10.1016/0028-2243(83)90097-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Uterine motility after post-partum application of sulprostone and other oxytocicsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1983
- PLASMA PROSTAGLANDIN IN PREGNANT-WOMEN WITH TERM AND PRETERM DELIVERIES1981
- The mechanism of prostaglandin action on the early pregnant human uterusProstaglandins, 1979
- The mechanism of prostaglandin action on the pregnant human uterusProstaglandins, 1979
- On the mechanism of action of 15-methyl-PGF2α as an abortifacientProstaglandins, 1979
- Plasma prostaglandin metabolites in human laborAmerican Journal of Obstetrics and Gynecology, 1978
- Postpartum uterine atony treated with prostaglandinsAmerican Journal of Obstetrics and Gynecology, 1977
- Effects of prostaglandins and oxytocin on calcium release from a uterine microsomal fraction.Journal of Biological Chemistry, 1977
- A radioimmunoassay for 13,14-dihydro-15-keto prostaglandin F2α with chromatography and internal recovery standardProstaglandins, 1977
- The effects of intramyometrial injection of prostaglandin F2α on severe post-partum hemorrhageProstaglandins, 1976